Posted by BilisMasin > 2021-06-04 10:41 | Report Abuse

Kanger is sin0p0rn.
No more sinopharm

Posted by Noobie123 > 2021-06-04 11:12 | Report Abuse

s://www.theedgemarkets.com/article/kanger-signs-mou-sabah-govt-procure-chinas-sinopharm-covid19-vaccines

"Under the MoU, Kanger will source the Sinopharm vaccines from abroad to be supplied to the Sabah Government, while the State Government appoints Kanger as the exclusive distributor of the vaccines in the State, subject to the approval of the Federal regulatory authorities."

This statement showed Kanger is NOT YET the exclusive agent for Malaysia.

Posted by Noobie123 > 2021-06-04 11:35 | Report Abuse

" KIB will also undertake the marketing and promotion of Sinopharm Group's products in Malaysia, however, both parties will sign a separate agreement in regards to specific product category, price, purchase price and payment method."

So where is this agreement? Not disclosed yet to Bursa?

Posted by MZM2511 > 2021-06-04 11:37 | Report Abuse

@nOOBIE123.

2. Kanger had entered a collaboration agreement with China-based Sinopharm Group Hunan Changde Medical Co Ltd (Sinopharm Group) for the distribution of Covid-19 vaccines developed by China National Biotech Group Company (CNBG) in Malaysia.

Under the agreement, Sinopharm Group has appointed KIB as the SOLE DISTRIBUTOR for the vaccines, medical devices and products in Malaysia. KIB will also undertake the marketing and promotion of Sinopharm Group's products in Malaysia, however, both parties will sign a separate agreement in regards to specific product category, price, purchase price and payment method.

(Remarks: This agreement shall take effect for a period of three years effective from 25 September 2020 until 24 September 2023)

Source: https://www.msn.com/en-my/news/national/kanger-sinopharm-inks-agreement-for-covid-19-vaccine-distribution-in-malaysia/ar-BB19x0Lr

Posted by MZM2511 > 2021-06-04 11:47 | Report Abuse

@Noobie123. So where is this agreement? Not disclosed yet to Bursa?
---------------------------------
SILA RUJUK SINI WAHAI NO NEWBIE... HE HE

OTHERS Kanger International Berhad ("Kanger" or "Company") and its subsidiary companies ("Group") - Collaboration Agreement with Sinopharm Group Hunan Changde Medical Co. Ltd.

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3092107

Posted by MZM2511 > 2021-06-04 12:02 | Report Abuse

1. Perjanjian sebagai SOLE DISTRIBUTOR yang dilantik untuk 3 tahun oleh Sinopharm dah ada - SETTLE

Sumber: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3092107

2. MOU untuk wakil distributor bagi pihak Kanger dah ada iaitu Zuellig Pharma - SETTLE

Sumber:
1. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3154098
2. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3137884

Nota: Kanger will collaborate with ZP to facilitate the import, warehousing, and
distribution of Covid-19 vaccines in Malaysia. Kanger will receive 10,000 doses of a Covid-19 vaccine developed by state-owned China National Pharmaceutical Group Corp (Sinopharm) for trial purposes. The first batch of vaccines is expected to arrive in Malaysia on May 2021).


3. MOU untuk saluran jualan vaksin ke kilinik swasta di Malaysia dah ada iaitu KSport - SETTLE

Sumber:

1. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3154097
2. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3137884

SEKARANG TUNGGU UNTUK PROSES APPROVAL OLEH KERAJAAN DAN NPRA SAHAJA.

Posted by Noobie123 > 2021-06-04 12:06 | Report Abuse

@MZM2511 ....I look up and look down...still cannot find the word "SOLE DISTRIBUTOR. "

1. Sinopharm got 2 types of vaccine Wuhan & Bejing. Which vaccine are we talking about. WHO approved which vaccine? Did Kanger sign for the approved type of vaccine?

2. Is Sinopharm Changde Hunan is authorised for overseas export of Sinopharm. Are you sure Kanger signed with the right party? What type of operations does Changde Hunan really do?

3. Separate agreement on type of product to be signed between Sinopharm and Kanger. Where is it?

I am interested to know the above..pls share if you got more info.

Posted by MZM2511 > 2021-06-04 12:18 | Report Abuse

Noobie123. I look up and look down...still cannot find the word "SOLE DISTRIBUTOR. "

-----------------------
Yes there is a discrepancy there:
1. Based on announcent @ KLSE.
Just stated as distributor

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3092107

2. Based on MSN news report.
Under the agreement, Sinopharm Group has appointed KIB as the sole distributor for the
vaccines, medical devices and products in Malaysia.

Source: https://www.msn.com/en-my/news/national/kanger-sinopharm-inks-agreement-for-covid-19-vaccine-distribution-in-malaysia/ar-BB19x0Lr

Posted by MZM2511 > 2021-06-04 14:24 | Report Abuse

Question 1. Sinopharm got 2 types of vaccine Wuhan & Bejing. Which vaccine are we talking about. WHO approved which vaccine? Did Kanger sign for the approved type of vaccine?
------------------------

Kanger had entered a collaboration agreement with China-based Sinopharm Group Hunan Changde Medical Co Ltd (Sinopharm Group) for the distribution of Covid-19 vaccines developed by China National Biotech Group Company (CNBG) in Malaysia.

Additional information related:

1. China National Biotec Group (CNBG), is a subsidiary of China National Pharmaceutical Group Corporation (SINOPHARM).

2. Sinopharm vaccine Sinopharm / BIBP1 or SARS-CoV-2 - BIBP1 was developed through a collaboration between the Chinese Center for Disease Control and Prevention (CDC) and the Beijing Institute of Biological Products (BIBP)/China National Biotec Group Company Limited (CNBG).

3. CNBG is also developing another vaccine, Sinopharm / WIBP1 or SARS-CoV-2 - WIBP1.

4. The Sinopharm / BIBP1 vaccine has been approved by WHO on 7 May 2021, where as Sinopharm / WIBP1 is still under its assessment process by WHO.


As a conclusion, BOTH OF THE VACCINES ARE RELATED TO CNBC, AND CAN BE DISTRIBUTED BY CANGDE MEDICAL CO. LTD. But I thinks its better for Kanger to focus more on currently approve vaccine, it is Sinopharm / BIBP1.

Posted by MZM2511 > 2021-06-04 14:25 | Report Abuse

@Noobie123.

Question 2. Is Sinopharm Changde Hunan is authorised for overseas export of Sinopharm. Are you sure Kanger signed with the right party? What type of operations does Changde Hunan really do?
---------------------

I am not sure about Sinopharm Hunan Changde Medical Co. Ltd. authorisation to export of Sinopharm vaccine.

But, the existence of this company and its relation with Sinopharm Group of company can be verified as follows:

Sinopharm, Hunan Changde Medical is a company incorporated in the People Republic of China (“PRC”) with a business address at No. 22, 3rd Floor, Zone A, Tower 2, Long Mei Street, Changde Economic and Technological Development Changde, Hunan Province, PRC. Sinopharm Hunan Changde is principally engaged in sale of medical supplies and equipment, and is part of Sinopharm Group, which is a large Chinese state-owned healthcare group.

(Note: The Sinopharm Group Hunan Changde Medical Co. Ltd. existence can be checked @ this web link: http://www.info-clipper.com/en/company/china/sinopharm-holding-hunan-changde-medical-equipment-co-ltd.cnd9657ed.html ).

And also, there is an evidence base on the report that,
"Kanger will receive 10,000 doses of a Covid-19 vaccine developed by state-owned China National Pharmaceutical Group Corp Sinopharm) for trial purposes"

(Note: https://www.theedgemarkets.com/article/kanger-receive-10000-doses-sinopharm-covid19-vaccine%C2%A0-may-trial-purposes )


My conclusion is Sinopharm Hunan Changde Medical Co. Ltd. is exist and Kanger suppose to import the Sinopharm vaccine via Sinopharm Hunan Changde Medical Co. Ltd.'s dealearship.

Posted by MZM2511 > 2021-06-04 14:26 | Report Abuse

@Noobie123.
Separate agreement on type of product to be signed between Sinopharm and Kanger. Where is it?
--------------------
I can't get any upadated info about this.
May be they not yet sign it.

But I think the signing detail about it not so material because the major agreement deal has been signed and announced @ KLSE.

Posted by Noobie123 > 2021-06-04 15:11 | Report Abuse

@MZM2511 TQ for info. I am not trying to be difficult but to ask critical questions. From info clipper, you will see there are another 969 companies in Sinopharm Group itself. So who is really calling the shots in exporting vaccine.

Posted by MZM2511 > 2021-06-04 15:14 | Report Abuse

@Noobie. As stated in the company's report to Bursa and media, it should be as stated, It is Hunan Changde Medical Equipment Co., Ltd

Posted by BilisMasin > 2021-06-04 15:14 | Report Abuse

Operator try to finish their stock at 0.075
Creating blockage st 0.070

Sign of no hope

Posted by Hasli1987 > 2021-06-04 15:56 | Report Abuse

On 25 May, ex deputy health minister suggested kkm to overrule npra..
Kj also mentioned that states can purchase sinopharm..

However I don't think kkm overruled NPRA.. So this MOU, I think not going to be completed within short of times..

Just my thoughts

Posted by MZM2511 > 2021-06-04 16:06 | Report Abuse

SHAH ALAM - Tempoh penilaian permohonan lengkap bagi pendaftaran bersyarat untuk vaksin Covid-19 telah dipendekkan daripada 245 hari kepada 120 hari bekerja.

Posted by Noobie123 > 2021-06-04 16:13 | Report Abuse

No way MOH will allow anyone to overrule NPRA. Who is going to be responsible if vaccine got problems and people start to die. It is not just one case but hundred of thousands are involved.

Posted by Noobie123 > 2021-06-04 16:17 | Report Abuse

Car breakdown can still repair. Human organs breakdown cannot replaced. Medical quality control are super tight. Politicians come and go. Frontliners have responsibility for the rest of their life.

Posted by Hasli1987 > 2021-06-04 16:18 | Report Abuse

Yup.. No way it going to happened
Yup 120 working days equivalent to 6 month.. So end of the year la

Posted by BilisMasin > 2021-06-04 16:34 |

Post removed.Why?

Posted by 858411123 > 2021-06-04 16:44 | Report Abuse

RIGHTS ISSUE WITH WARRANTS APPROVED! TIME TO FLY SOON?!

Seasoned investors that are familiar with corporate exercise would definitely be no stranger to rights issue. But for new investors, rights issue is commonly a way for listed companies to raise additional capital from shareholders – sometimes it also comes with a sweetener, warrant.

How impactful is warrant on the share price? Just take a look at these few companies share price after bonus issue or rights issue that comes with warrant.

Posted by 858411123 > 2021-06-04 16:44 | Report Abuse

Of course, there are plenty more examples where companies that issued free warrants might spike up. But why is that so?

Warrant – as a financial derivative which carries the ability to allow its holder to have the right but not obligated to convert it into mother share, often seen as an opportunity to arbitrage. It is an advanced technique that often used by seasoned investors but to put it in plain English, some big holders of warrant might “push” the mother share price to increase the attractiveness in warrant due to the conversion gap and the arbitrage opportunity.

However, Kanger International Berhad (KLSE: KANGER) – the recent darling of vaccine theme play had finally gotten their approval from Bursa for the rights issue that comes along with the warrant sweetener.

Posted by 858411123 > 2021-06-04 16:44 | Report Abuse

How do we know for sure KANGER might fly anytime soon? To answer this question, we must study the price movement pattern of the company.

As you can see, the company had a downturn in share price and momentum since the vaccine market was slammed hard by the government. But what we could tell from the chart is that there is an attempt to breakout on 28th May 2021. What could possibly trigger the buying momentum?

After going around several forums and platforms, I noticed that there are already rumours being spread on KANGER’s rights issue shall be approved at anytime soon. Perhaps this spiked the buying interest – but unfortunately, the company only announced the good news on yesterday, hence investors might have got in too early.

Nevertheless, with the approval for warrants, I’m sure that KANGER will continue to fly once operator had finished the accumulation of shares – which they already did since 2019 to 2020 and washed most new investors off KANGER by now.

Posted by 858411123 > 2021-06-04 16:45 | Report Abuse

From technical analysis + corporate news standpoint, we could begin our execution on the trade. The for-sure support level for the company is at 6.0 cents level. And the most recent resistance of the company would be at 11.5 cents and 15.0 cents, respectively. This represents a potential downside risk of 20.0%, and for the upside, that would be between 53.3% and 100.0%, representing a risk-to-reward ratio of 2.6 times to 5.0 times!

On the back of years of my trading experience, KANGER will definitely ride on the positive news and depart soon. Do not miss out the ride on this company!

https://klse.i3investor.com/blogs/unspokerules/2021-06-03-story-h1566017345-RIGHTS_ISSUE_WITH_WARRANTS_APPROVED_TIME_TO_FLY_SOON.jsp

Posted by BilisMasin > 2021-06-04 16:49 | Report Abuse

Fake news

Posted by MadCow75 > 2021-06-04 19:22 | Report Abuse

ikan bilis oh ikan bilis, boring lar... pls create new wording.. u tak seinz me also seinz... pls give fact lar... ppl pay u to write negative not only repeat and repeat ony few word... do homework ...

Posted by MadCow75 > 2021-06-04 19:24 | Report Abuse

noobie my old fren... not sure u still hold kanger or not... so u must be more understanding why vaccine approval need so many time... roti canai punya pasal... roti belum habis jual, nasi lemak coming, who wan buy roti canai...

Posted by BilisMasin > 2021-06-04 19:42 | Report Abuse

Ah kau orang pun sama kaki goreng

Posted by MadCow75 > 2021-06-04 19:50 | Report Abuse

just see how this roti canai drama going on... but now private vaccine is our age stage last hope, i cannot manage to reg AZ, so waiting for private pay vaccine, only the fastest way...

Posted by MadCow75 > 2021-06-04 19:51 | Report Abuse

sinopharm is so near but look so far away..

Posted by MZM2511 > 2021-06-04 21:00 | Report Abuse

China to supply 1 billion vaccine doses overseas by year end - Global Times

Source: https://www.theedgemarkets.com/article/china-supply-1-billion-vaccine-doses-overseas-year-end-global-times#.YLoaa4Qn1UM.telegram

My remarks:
1. Wuhan Institute of Biological Products saya rasa satu lagi vaksin oleh Sinopharm, Sinopharm / WIBP2. WIBP tu ialah Wuhan Institute of Biological Products.

2. Yang dah lulus 7 Mei tu, Vaksin Sinopharm / BIBP1 vaccine was developed through a collaboration between the Chinese Center for Disease Control and Prevention (CDC) and the Beijing Institute of Biological Products (BIBP)/China National Biotec Group Company Limited (CNBG).

3. Kedua-duanya melibatkan CNBG yang dikaitkan dengan perjanjian distribution dengan Kanger

Posted by MZM2511 > 2021-06-04 21:06 | Report Abuse

Meanwhile, referring to social media reports, the Chinese Embassy of Sri Lanka said the Bangladesh has not yet finalized their procurement agreement including pricing.

“We checked with Chinese Embassy in Dhaka as well as #Sinopharm group. Bangladesh Health Minister has clarified last week that their procurement agreement including pricing is not finalized yet. The fake news on social media has already disturbed their ongoing negotiation,” the Chinese Embassy said.

Posted by MadCow75 > 2021-06-04 21:27 |

Post removed.Why?

Posted by hlh1962 > 2021-06-04 22:04 | Report Abuse

Talk positive with facts and negative with facts also. Really no need keep on repeating the same words over and over again. Make it interesting for all the investors to read.

Posted by MadCow75 > 2021-06-05 00:29 | Report Abuse

10000 dose is bring in for NPRA trial at end May, but now seen 5000 foc to sabah state... so another 5000dose?? u may chk back kanger annoucement... will very close.. just see how NPRA work.. Malaysia style.. last minute... ????

Posted by BilisMasin > 2021-06-05 00:32 | Report Abuse

There is no more chance for Sinopharm to enter Malaysia

Roti canai sudah order Pfizer sama AstraZeneca untuk Program Imunisasi Kebangsaan [PIK] (which is previously Astrazeneca being excluded from PIK).

Pfizer order only would be enough to cover 70% of Malaysian population
Belum campur AstraZeneca, maybe enough cover 80-85% Malaysian population
----------------------
News Straight Time (27 May 2021)
https://www.straitstimes.com/asia/se-asia/malaysia-to-procure-128-million-more-doses-of-pfizer-biontech-covid-19-vaccines

KUALA LUMPUR (REUTERS, BLOOMBERG) - Malaysia will procure an additional 12.8 million doses of the coronavirus vaccine jointly developed by Pfizer and BioNTech in a bid to ramp up its immunisation programme, Science Minister Khairy Jamaluddin said on Thursday (May 27).

The procurement brings the total amount of doses secured from the US and German drugmakers to 44.8 million, enough to cover 70 per cent of Malaysia's population, Mr Khairy said.
----------------------

Looking at current situation;

- Bila Kanger tarikh exactly submit application Sinopharm to NPRA (Tak tahu)
- Kalau dah submit, bila NPRA nak approve (120 hari dari submission - 6 bulan wooo)

By the time dah approve, 80% sudah vaccinated.

Tinggal 20% aja (belum tolak AntiVaxx) itu pun jika mereka nak bayar vaksin sendiri

Berapa aja tinggal market share untuk Kanger ?
Profitablekah lagi ?

Sekarang ni technical out, fundamental out. Tinggal Hope analysis saja

Posted by hlh1962 > 2021-06-05 00:40 | Report Abuse

Bilis masin what you say is true . But maybe anything can happen. Malaysia bolehland

Posted by MZM2511 > 2021-06-05 02:26 | Report Abuse

Sekarang ni technical out, fundamental out. Tinggal Hope analysis saja
------------------------
Perniagaan Covid-19 vaksin bukan fundamental bagi syarikat. Ianya sekadar BONUS.
Secara fundamentalnya perniagaan asalnya berkaitan bamboo floring dan berkaitan masih berjalan dan dalam usaha untunk dikembangkan lagi. Selain itu terdapat beberapa projek lain dirangka termasuk yang terbaharu melibatkan pembelian 51% syarikat berasaskan perniagaan pembekal bahan binaan yang agak kukuh dari segi perniagaannya. Ini antaranya.

Dari segi teknikal pula, memang harga saham akan jatuh dan naik mengikut keadaan pasaran saham secara keseluruhan dan keadaan berkaitan dengan kaunter itu sendiri secara spesifik. Kalau harganya dalam trend mnurun pun akan sampai masa supportnya, dari dari situ mungkin akan beralih trendnya, juga mengikut keadaan pasaran saham secara keseluruhan dan keadaan yang berlaku atau mungkin akan berlaku di dalam kaunter itu sendiri.

Jangka masa pendek ini, saya tertarik untuk melihat bagaimana respon terhadap harga saham Kanger sebelum RI dilaksanakan nanti.

Posted by ariff18 > 2021-06-05 09:27 | Report Abuse

jangan gaduh2, yang masih minat dan yakin stay saja, yang tak yakin cutloss & go other counter yang menguntungkan

duit masing2 pandai lah mereka urus

rugi atau untung semua itu adat pelaburan & kehidupan

vaksin untuk swasta hanya boleh di beli selepas ini suku 3 2021 ke atas

https://www.sinarharian.com.my/article/130915/KHAS/Covid-19/Hospital-Swasta-akan-dibenar-berunding-beli-vaksin-Covid-19

Posted by Noobie123 > 2021-06-05 09:53 | Report Abuse

Selangkah Sinovac cost is RM380 for 2 doses. Can Sinopharm beat this price?

Kanger want to make $, Zueligg want to make $, Kstar want to make $, Klinik wan to make $...so people pay how much?

Posted by MZM2511 > 2021-06-05 11:01 | Report Abuse

According to the Daily Mirror, Sri Lanka is paying $15 per dose for the Sinopharm vaccine, which is USD 5 higher than what Bangladesh paid.

Posted by Noobie123 > 2021-06-05 11:07 | Report Abuse

https://www.livemint.com/news/world/highprice-china-s-sinopharm-vaccine-sparks-row-in-sri-lanka-11622425570626.html

Posted by Noobie123 > 2021-06-05 11:09 | Report Abuse

G to G price and private purchase price same?

Posted by Luckybull > 2021-06-05 11:19 | Report Abuse

Advice, better run if ri is on. So many companies use ri and foc warrant to con the greedy and naive ikan bilis. Look around so many penny stocks recently do the same modus operandi.

Posted by grateful > 2021-06-05 11:40 | Report Abuse

I just wonder why people asking sell Kanger under this forum ? Savior or buy low ?

Posted by MadCow75 > 2021-06-05 12:26 | Report Abuse

some ppl, when price drop to 6sen, hope can get 5sen, but suddenly bounce up... so cant get cheap ticket... keep on barking to scare ppl throw ticket hope can get cheap ticket they miss... dog never change the way of eat shit... ikan bilis still ikan bilis, always eat by other, they will never grow up... bcoz of their habit, suka jadi ikan bilis...

Posted by MadCow75 > 2021-06-05 12:29 | Report Abuse

more and more country enter to private pay vaccinate.. coz by q and wait.. cant even chase the way of mutation of virus...

Posted by MZM2511 > 2021-06-05 13:51 | Report Abuse

The price of Covid-19 Vaccines (updated 26 May 2021)

1. Pfizer-BioNTech - $19.50 per dose for first 100 million doses
2. Moderna - $25-$37 per dose
3. AstraZeneca-University of Oxford - $2.15 (U.S.) in the EU; $3-4 (U.S.) in the UK and U.S.; $5.25 (U.S.) in South Africa
4. Johnson & Johnson - $10 per dose
5. Russia’s Sputnik V Vaccine - $10 per dose
6. Sinovac Biotech - US$29.75 per dose in China ** edited: $5-$38 per dose in ASEAN
7. Novavax - $16 in the US
8. CanSino Biologics - Unknown
9. Bharat Biotech - Rp 150 or about $2 (U.S.), although that appears to be the low-end of the open-market price in India

*** to add:
10. Sinopharm - $15 per dose in Sri Lanka and $10 in Bangladesh

Source: https://www.biospace.com/article/comparing-covid-19-vaccines-pfizer-biontech-moderna-astrazeneca-oxford-j-and-j-russia-s-sputnik-v/

Posted by MZM2511 > 2021-06-05 17:29 | Report Abuse

Tambahnya, setakat ini, terdapat enam produk vaksin Covid-19 yang telah selesai dinilai oleh NPRA dalam masa yang ditetapkan dan telah mendapat kelulusan pendaftaran bersyarat daripada PBKD.

Katanya, pihak NPRA juga sedang menilai BEBERAPA PERMOHONAN BAHARU bersyarat vaksin-vaksin Covid-19 pada masa ini.

“Permohonan ini juga akan disegerakan dengan kaedah yang sama. NPRA sememangnya sentiasa terbuka menerima pandangan pelbagai pihak,” katanya

Source: https://www.kosmo.com.my/2021/05/25/npra-nafi-lewat-lulus-produk-vaksin-covid-19/

Posted by Hasli1987 > 2021-06-05 17:57 | Report Abuse

www.bharian.com.my › 2021/06
Web results
NPRA lulus satu lagi kajian klinikal vaksin COVID-19 - Berita Harian

Vero cell.. Sama ke dgn sinopharm.. Google mac sama